Logo of brjopthalBritish Journal of OphthalmologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Br J Ophthalmol. 1996 May; 80(5): 425–428.
PMCID: PMC505494

Systemic effects of screening for retinopathy of prematurity.


AIMS: To detect systemic complications of screening for retinopathy of prematurity (ROP), paying particular attention to the physical examination. METHODS: Oxygen saturation, pulse rate, and blood pressure were monitored before, during, and after 110 ROP screening examinations. RESULTS: Following topical mydriatics diastolic blood pressure was elevated by a mean of 6 (SD 7.2) mm Hg. Immediately after the examination there was a further rise in both systolic and diastolic pressure of 4.3 (14.5) mm Hg and 3.3 (11.6) mm Hg, respectively. Oxygen saturation and pulse rate remained stable during the control period and administration of eyedrops. Saturation fell by a median of 3% (95% confidence interval plus or minus 1.2%) after the examination while there was rise in pulse rate of 7 (SD 23.1) beats per minute. This change in pulse rate was not observed in infants on concurrent methylxanthine therapy. No infant had clinically significant changes at the end of the study. CONCLUSION: The initial changes in blood pressure may represent side effects of topical mydriatics but the later changes following the physical examination may be an additional response to the stress of ROP screening.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (810K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye (Lond) 1992;6(Pt 3):233–242. [PubMed]
  • Schulenburg WE, Acheson JF. Cryosurgery for acute retinopathy of prematurity: factors associated with treatment success and failure. Eye (Lond) 1992;6(Pt 2):215–220. [PubMed]
  • Javitt J, Dei Cas R, Chiang YP. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics. 1993 May;91(5):859–866. [PubMed]
  • Bauer CR, Trottier MC, Stern L. Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant. J Pediatr. 1973 Mar;82(3):501–505. [PubMed]
  • Isenberg S, Everett S, Parelhoff E. A comparison of mydriatic eyedrops in low-weight infants. Ophthalmology. 1984 Mar;91(3):278–279. [PubMed]
  • Isenberg SJ, Abrams C, Hyman PE. Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants. Ophthalmology. 1985 May;92(5):698–700. [PubMed]
  • Lahdes K, Huupponen R, Kaila T, Ali-Melkkilä T, Salminen L, Saari M. Systemic absorption of ocular cyclopentolate in children. Ger J Ophthalmol. 1992;1(1):16–18. [PubMed]
  • Bolt B, Benz B, Koerner F, Bossi E. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157–162. [PubMed]
  • Lees BJ, Cabal LA. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. Pediatrics. 1981 Aug;68(2):231–234. [PubMed]
  • Clarke WN, Hodges E, Noel LP, Roberts D, Coneys M. The oculocardiac reflex during ophthalmoscopy in premature infants. Am J Ophthalmol. 1985 Jun 15;99(6):649–651. [PubMed]
  • Dewar KM. The oculocardiac reflex. Proc R Soc Med. 1976 May;69(5):373–374. [PMC free article] [PubMed]
  • Borromeo-McGrail V, Bordiuk JM, Keitel H. Systemic hypertension following ocular administration of 10 per cent phenylephrine in the neonate. Pediatrics. 1973 Jun;51(6):1032–1036. [PubMed]
  • Palmer EA. How safe are ocular drugs in pediatrics? Ophthalmology. 1986 Aug;93(8):1038–1040. [PubMed]
  • Lynch MG, Brown RH, Goode SM, Schoenwald RD, Chien DS. Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. Arch Ophthalmol. 1987 Oct;105(10):1364–1365. [PubMed]
  • Wheatcroft S, Sharma A, McAllister J. Reduction in mydriatic drop size in premature infants. Br J Ophthalmol. 1993 Jun;77(6):364–365. [PMC free article] [PubMed]
  • Bates JH, Burnstine RA. Consequences of retinopathy of prematurity examinations. Case report. Arch Ophthalmol. 1987 May;105(5):618–619. [PubMed]
  • Brown GC, Tasman WS, Naidoff M, Schaffer DB, Quinn G, Bhutani VK. Systemic complications associated with retinal cryoablation for retinopathy of prematurity. Ophthalmology. 1990 Jul;97(7):855–858. [PubMed]
  • Batton DG, Ivery P, Trese M. Respiratory complications associated with cryotherapy in premature infants. Am J Perinatol. 1992 Jul;9(4):296–298. [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...